Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
It comes in dried sheets of seaweed
The increased cost and additional injection requirement mean the combination approach represents a step up in commitment
Scientific Communications: imaging 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.06 - IMAGING - Hyperacute O - ESOC25-1780 PERFORMANCE OF A NON-CONTRAST CT SOFTWARE FOR THE IDENTIFICATION OF LARGE VESSEL OCCLUSION STROKE IN THE EXTENDED WINDOW Brbara Yugueros-Baena 1 , Adrin Valls 1 , Cristian Marti 2 , Monica Millan 1 , Carlos Castao 1 , Alan Flores 3 , Yolanda Silva 4 , Francisco Purroy 5 , David Cnovas 6 , Pere Cardona 7 , Marta Olive 8 , Pol Camps Renom 9 , Xabier Urra 10 , Ana Rodrguez-Campello 11 , Mara Hernndez-Prez 1 1 Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 2 Methinks Software, Barcelona, Spain, 3 Hospital Joan XXIII, Tarragona, Spain, 4 Hospital Universitari Dr Josep Trueta, Girona, Spain, 5 Hospital Universitari Arnau de Vilanova, Lleida, Spain, 6 Hospital Universitari Parc Taul, Sabadell, Spain, 7 Hospital Universitari de Bellvitge, LHospitalet de Llobregat, Spain, 8 Hospital Universitari Vall d'Hebron, Barcelona, Spain, 9 Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 10 Hospital Clinic Barcelona, Barcelona, Spain, 11 Hospital del Mar, Barcelona, Spain Background and Aims: The detection of large vessel occlusion (LVO) in patients with acute ischemic stroke (AIS) is usually assessed by advanced imaging in the extended window, but in some settings, as primary stroke centers or stroke-ready centers only non-contrast CT (NCCT) is available
Weeks 8 through 16: titration phase Gradually increase retatrutide dose following standard titration (2mg, then 4mg, then 8mg at 4-week intervals)
US$ 28.44
US$ 20.81
US$ 21.67
US$ 26.81
US$ 26.33
US$ 22.19
